Melatonin slowed the early biochemical progression of hormone-refractory prostate cancer in a patient whose prostate tumor tissue expressed MT1 receptor subtype.
about
WOMEN IN CANCER THEMATIC REVIEW: Circadian rhythmicity and the influence of 'clock' genes on prostate cancerMT1 and MT2 Melatonin Receptors: A Therapeutic PerspectiveTherapeutic treatments potentially mediated by melatonin receptors: potential clinical uses in the prevention of osteoporosis, cancer and as an adjuvant therapyMelatonin, a Full Service Anti-Cancer Agent: Inhibition of Initiation, Progression and Metastasis.Expression of the MT1 melatonin receptor in ovarian cancer cells.Urinary melatonin levels, sleep disruption, and risk of prostate cancer in elderly menCircadian disruption, sleep loss, and prostate cancer risk: a systematic review of epidemiologic studiesMelatonin: bone metabolism in oral cavity.Sleep disruption among older men and risk of prostate cancer.Towards rational and evidence-based use of melatonin in prostate cancer prevention and treatment.Melatonin represses oxidative stress-induced activation of the MAP kinase and mTOR signaling pathways in H4IIE hepatoma cells through inhibition of Ras.Melatonin, the circadian multioscillator system and health: the need for detailed analyses of peripheral melatonin signaling.Melatonin and cancer.Melatonin Inhibits Androgen Receptor Splice Variant-7 (AR-V7)-Induced Nuclear Factor-Kappa B (NF-κB) Activation and NF-κB Activator-Induced AR-V7 Expression in Prostate Cancer Cells: Potential Implications for the Use of Melatonin in Castration-ResiMelatonin MT1 receptor-induced transcriptional up-regulation of p27(Kip1) in prostate cancer antiproliferation is mediated via inhibition of constitutively active nuclear factor kappa B (NF-κB): potential implications on prostate cancer chemopreventMelatonin synergistically enhances cisplatin-induced apoptosis via the dephosphorylation of ERK/p90 ribosomal S6 kinase/heat shock protein 27 in SK-OV-3 cells.Melatonin modulation of intracellular signaling pathways in hepatocarcinoma HepG2 cell line: role of the MT1 receptor.Functional interplay between melatonin receptor-mediated antiproliferative signaling and androgen receptor signaling in human prostate epithelial cells: potential implications for therapeutic strategies against prostate cancer.Signaling mechanisms of melatonin in antiproliferation of hormone-refractory 22Rv1 human prostate cancer cells: implications for prostate cancer chemoprevention.Melatonin induces apoptosis in human neuroblastoma cancer cells.Differential effects of melatonin and its downstream effector PKCalpha on subcellular localization of RGS proteins.Melatonin reduces prostate cancer cell growth leading to neuroendocrine differentiation via a receptor and PKA independent mechanism.MT1 melatonin receptor expression in Warthin's tumor.Melatonin protects against cisplatin-induced ovarian damage in mice via the MT1 receptor and antioxidant activity.Inhibitory effects of melatonin on the growth of pituitary prolactin-secreting tumor in rats.
P2860
Q28077467-6A3657D4-4384-4657-8829-C3CF629CB8C7Q28083929-E2068036-2C6D-48F2-BAFB-D76A4C8C2437Q28266443-D32071F9-DB24-4F85-BEA6-5F78915F0109Q33624824-31C732F2-0C53-4EB2-905C-2EB8C6CF347DQ34835245-E769D78B-D9B7-4164-B394-043E266E6885Q35054661-9F36D4CC-3554-4563-BA8F-866C193281F5Q36083886-CF7A6114-1B7B-4E11-A7BB-231FFB8CEE34Q36178389-A9143F0F-B905-4B5C-9690-414B4023F2AFQ36839618-09A81B43-861B-4376-ABF6-211EA2DC9BB1Q36872043-016E57F9-0EBA-42DE-A35D-CC4B489F8B7FQ37088995-FEC0DB7E-AAF8-4305-B9A9-848AF53B4D02Q37950409-B6962182-CCE4-4003-AB73-032E611A2491Q38269497-D34AF604-ADB9-4262-A5E2-3417C164A3EAQ38754474-4B9565C2-DD40-4888-A5EC-96BDF2234249Q39303608-1EED306C-D46E-4E6E-BC9C-17F18BA3D106Q39448599-110704F7-A28F-4915-ABC6-DC5E84D26110Q39515321-52E708C6-73FE-47BE-AAA6-F975EB007A80Q39538005-2DA6A0E8-65DE-49E0-87CF-7125CD7D5050Q40173621-C985CD61-24CC-46A4-A688-DF6BB5886192Q40249613-A6311DC8-83E2-426E-8E1B-D12863F062CCQ40324169-6F311E38-F293-4247-AE3C-88017F1ED15FQ40513840-BD11592A-76B8-4770-AB7A-7B6BCC4595BAQ42514286-9DC3BBF7-A863-4DE0-931C-DC0495083997Q46354075-884FE3BB-ABC3-4EF3-8DF1-3EE09CB31E7AQ46961843-6503AFC3-032F-47E7-B770-57DD4B40A0B3
P2860
Melatonin slowed the early biochemical progression of hormone-refractory prostate cancer in a patient whose prostate tumor tissue expressed MT1 receptor subtype.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Melatonin slowed the early bio ...... xpressed MT1 receptor subtype.
@en
Melatonin slowed the early bio ...... xpressed MT1 receptor subtype.
@nl
type
label
Melatonin slowed the early bio ...... xpressed MT1 receptor subtype.
@en
Melatonin slowed the early bio ...... xpressed MT1 receptor subtype.
@nl
prefLabel
Melatonin slowed the early bio ...... xpressed MT1 receptor subtype.
@en
Melatonin slowed the early bio ...... xpressed MT1 receptor subtype.
@nl
P2093
P1476
Melatonin slowed the early bio ...... xpressed MT1 receptor subtype.
@en
P2093
Andrew W C Yip
Stephen Y W Shiu
P304
P356
10.1034/J.1600-079X.2003.00074.X
P577
2003-10-01T00:00:00Z